The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

• Status: Not yet recruiting
• Trial end date: 2024-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chulalongkorn University
• Treatments: Empagliflozin

Criteria

Inclusion Criteria:

• post AKI stage 2-3

• CrCl > 20

Exclusion Criteria:

• pregnancy

• post kidney transplant

• previous use of SGLT2 Inhibitors

• history of ketoacidosis